Three Novel Myeloma Therapies

Three Novel Myeloma Therapies

April 24 @ 12:00pm — 1:35pm EDT

Three new drug treatments have been added to the treatment arsenal for myeloma, two recently approved by the U.S. Food and Drug Administration (FDA) and one for other cancers that is now being studied in phase 3 clinical trials.  Three myeloma experts who participated in clinical trials for each one will discuss each treatment in detail and answer questions submitted by registered viewers.

Schedule & Agenda

April 24 @ 12:00pm — 1:35pm EDT

12:00pm

Jennifer Ahlstrom

Three Novel Myeloma Therapies

Welcome and Introduction of Faculty

12:05pm

Jonathan Kaufman, MD

Three Novel Myeloma Therapies

Venetoclax

12:20pm

Peter Voorhees, MD

Three Novel Myeloma Therapies

Melflufen

12:35pm

Michaela Liedtke, MD

Three Novel Myeloma Therapies

Ide-cel CAR T

12:50pm

Full Faculty

Three Novel Myeloma Therapies

Audience Questions and Answers

Speakers & Moderators

Jennifer Ahlstrom

Jenny A - Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical trials...

Read Bio

Peter Voorhees, MD

Peter Voorhees, MD, is Director of Outreach and Clinical Operations for Hematologic Malignancies and a Member of the Plasma Cells Disorder Program at the Levine Cancer Institute in...

Read Bio

Jonathan Kaufman, MD

Jonathan Kaufman, MD, is Associate Professor and Associate Vice-Chair for Quality and Safety of the Department of Hematology and Medical Oncology at the Emory University School of ...

Read Bio

Greg Brozeit

Greg is the Program Director for the Myeloma Crowd patient education programs. He is based in Northeast Ohio....

Read Bio

Michaela Liedtke, MD

Michaela Liedtke, MD, is Associate Professor of Medicine (Hematology) at the Stanford University Medical Center in Palo Alto, CA and Co-Director of the Stanford Amyloid Center. Sh...

Read Bio

About the Myeloma Crowd Round Tables (MCRTs)

About the Myeloma Crowd Round Tables (MCRTs)

Myeloma Crowd Round Tables (MCRTs) are education programs for myeloma patients and caregivers on a variety of treatment and research issues.  Each MCRT features presentations from internationally-recognized myeloma experts who also take extensive Q&A sessions from audience members.

Register Today!

April 24 @ 12:00pm — 1:35pm EDT

Event Sponsors





Thanks to our Myeloma Crowd Community sponsors:

.                         .